2025. COMPARATIVE IMMUNE MICROENVIRONMENT PROFILING IN HBV-, HCV-, AND DUAL-INFECTED HEPATOCELLULAR CARCINOMA: TOWARD ETIOLOGY-SPECIFIC IMMUNOTHERAPEUTIC TARGETS. Frontier in Medical and Health Research. 3, 5 (Jul. 2025), 12–14.